Insider Trading: ARIAD Pharmaceuticals Inc (ARIA.O)

ARIA.O on Nasdaq

18.07USD
14 Jun 2013
Price Change (% chg)

$-0.04 (-0.22%)
Prev Close
$18.11
Open
$18.11
Day's High
$18.16
Day's Low
$17.56
Volume
2,322,065
Avg. Vol
3,179,736
52-wk High
$25.40
52-wk Low
$15.35

Search Stocks
LAVIDAS ATHANESE

Institutional Holders

% Shares Owned: 84.96%
# of Holders: 321
Total Shares Held: 156,916,970
3 Mo. Net Change: 21,487,642
# New Positions: 47
# Closed Positions: 27
# Increased Positions: 177
# Reduced Positions: 103
# Net Buyers: 74

Officers & Directors

Name Age Since Current Position

Harvey Berger

 63 2004 Chairman of the Board, President, Chief Executive Officer

Edward Fitzgerald

 58 2010 Chief Financial Officer, Executive Vice President, Treasurer

Raymond Keane

 54 2009 Senior Vice President, General Counsel, Secretary and Chief Compliance Officer

David Berstein

 61 2008 Senior Vice President, Chief Intellectual Property Officer

Daniel Bollag

 52 2009 Senior Vice President - Regulatory Affairs and Quality

Maria Cantor

 45 2012 Senior Vice President - Corporate Affairs

Pierre Dodion

 58 2012 Senior Vice President - Corporate Development and Operations

Martin Duvall

 50 2011 Senior Vice President - Commercial Operations

Frank Haluska

 54 2012 Senior Vice President - Clinical Research and Development and Chief Medical Officer

Timothy Clackson

 48 2010 President - Research and Development, Chief Scientific Officer

Athanase Lavidas

 65 2008 Lead Independent Director

Jay LaMarche

 66 2000 Independent Director

Massimo Radaelli

 55 2008 Independent Director

Norbert Riedel

 55 2011 Independent Director

Robert Whelan

 61 2010 Independent Director

Wayne Wilson

 64 2008 Independent Director

Kendra Adams

 Director - Investor Relations
Search Stocks